RIPK1-IN-8
RIPK1-IN-8 (example 16), an aminoimidazopyridine, is a potent and selective RIPK1 inhibitor with an IC50 of 4 nM. RIPK1-IN-8 has the potential for inflammatory diseases research[1].
Product Specifications
CAS Number
[2319663-07-3]
UNSPSC
12352005
Target
RIP kinase
Type
Reference compound
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ripk1-in-8.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC(C2=NN3C(C=C2)=NC(NC(C)=O)=C3)=C(C)N=C1)NCC4=CC(F)=CC(F)=C4OCC5CC5
Molecular Formula
C26H24F2N6O3
Molecular Weight
506.50
References & Citations
[1]Michael E. Mertzman, et al. Aminoimidazopyridines as kinase inhibitors. WO2019089442A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
RIPK1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rat Monoclonal IL-22R alpha 1 Antibody (496514) [Janelia Fluor 549]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
FAB42941I 0.1 mL
Rat Monoclonal IL-22R alpha 1 Antibody (496514) [Janelia Fluor 549]
Ask
View Details 
FY-EM5628 96 Well
Mouse Taf4 (Transcription initiation factor TFIID subunit 4) ELISA Kit
Ask
View Details